These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Renaissance of amantadine in the treatment of Parkinson's disease. Blanchet PJ; Metman LV; Chase TN Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683 [No Abstract] [Full Text] [Related]
5. Is pathological gambling in Parkinson's disease reduced by amantadine? Lee JY; Kim HJ; Jeon BS Ann Neurol; 2011 Jan; 69(1):213-4; author reply 214-5. PubMed ID: 21280095 [No Abstract] [Full Text] [Related]
6. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease]. Dzudza M; Dzudza D Med Arh; 1974; 28(4):407-15. PubMed ID: 4613968 [No Abstract] [Full Text] [Related]
7. Amantadine in Parkinson's disease: pro and contra. Greulich W; Fenger E J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077 [TBL] [Abstract][Full Text] [Related]
8. Twenty-five years of amantadine therapy in Parkinson's disease. Danielczyk W J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075 [TBL] [Abstract][Full Text] [Related]
9. Motor fluctuations in Parkinson's disease. Crabb L Prof Nurse; 2000 Jan; 15(4):273-7. PubMed ID: 10983145 [TBL] [Abstract][Full Text] [Related]
10. Plasma amantadine concentrations in patients with Parkinson's disease. Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813 [TBL] [Abstract][Full Text] [Related]
11. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series. Singer C; Papapetropoulos S; Gonzalez MA; Roberts EL; Lieberman A Mov Disord; 2005 Jul; 20(7):873-7. PubMed ID: 15809995 [TBL] [Abstract][Full Text] [Related]
12. Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease. Gondim Fde A; Costa HA; Taunay TC; de Oliveira GR; Ferreira JM; Rola FH Mov Disord; 2010 Jul; 25(10):1505-6. PubMed ID: 20629118 [No Abstract] [Full Text] [Related]
13. Combined treatment in Parkinson's disease. Wheatley D Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232 [No Abstract] [Full Text] [Related]
14. [Comparison between the effects of L-dopa, prodipine and amantadine on the serum and CSF amino acid levels in Parkinson's disease (author's transl)]. Gründig E; Gerstenbrand F Wien Klin Wochenschr; 1980 Dec; 92(24):868-71. PubMed ID: 7222702 [TBL] [Abstract][Full Text] [Related]